Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration. Journal Article


Authors: Goyal, A; Churkin, A; Barash, D; Cotler, SJ; Shlomai, A; Etzion, O; Dahari, H
Article Title: Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration.
Abstract: Shortening duration of direct-acting antiviral therapy for chronic hepatitis C could provide cost savings, reduce medication exposure, and foster adherence and treatment completion in special populations. The current analysis indicates that measuring hepatitis C virus at baseline and on days 7 and 14 of therapy can identify patients for shortening therapy duration.
Journal Title: Open forum infectious diseases
ISSN: 2328-8957; 2328-8957
Publisher: Unknown  
Date Published: 2022